A total of 11 studies were included in this meta-analysis, including 6 studies on GLP-1 RA, 1 study on GLP-1 and GIP dual receptor agonists, 1 study on orlistat, 2 studies on phentermine-topiramate, and 1 study on naltrexone-bupropion (Additional file 1: Table S2) [22,23,24,25,26,27,28,29,30,31,32]. There were 8 placebo controls and 3 active drug controls studies with 1573 participants in the …
Read More »Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine
